CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), and Wacker...
Read moreA Covid-19 vaccine co-developed by pharmaceutical company AstraZeneca and the University of Oxford is seen as one of the most...
Read moreCCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies, and McMaster Innovation Park (MIP),...
Read moreMerck, a leading science and technology company, and Transcenta, a global biotherapeutics company, have announced a strategic technology collaboration to...
Read moreWuXi Biologics , a global company with leading open-access biologics technology platforms, and AB2 Bio Ltd., a Swiss advanced clinical-stage...
Read moreOne could witness slow revenue growth of Dose Contract Manufacturing Organizations in 2019. Expectations were high on its revival in...
Read moreRoche announced that the European Commission has approved Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of adult...
Read moreThe Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), União QuÃmica Farmacêutica Nacional and the Government of the State...
Read moreEli Lilly and Company and Incyte announced positive data for Olumiant will be presented at ACR Convergence 2020, the American...
Read moreSirio Europe – the leading European nutraceutical and pharmaceutical contract development and manufacturing organisation (CDMO), part of the Sirio group...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.